Screener
Imax IMAX R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Imax in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Imax’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 8:47 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-049300
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| 39,946 | 38,082 | 75,514 | 71,573 | |
| Gross margin | 62,896 | 53,602 | 108,707 | 106,778 |
| Selling, general and administrative expenses | 34,528 | 35,302 | 67,016 | 68,764 |
| Research and development | 1,655 | 1,542 | 3,459 | 2,860 |
| Amortization of intangible assets | 2,164 | 1,809 | 4,192 | 3,540 |
| Credit loss expense (reversal), net | 1,481 | (183) | 1,021 | (309) |
| Restructuring charges and other impairments | 2,294 | 786 | 2,294 | 843 |
| Income from operations | 20,774 | 14,346 | 30,725 | 31,080 |
Item 1. Financial Statements
FAQ
- What is Imax's R&D?
- Imax (IMAX) reported R&D of $1.66M in Q2 2026.
- How has Imax's R&D changed year-over-year?
- Imax's R&D increased by 7.3% year-over-year, from $1.54M to $1.66M.
- What is the long-term trend for Imax's R&D?
- Over 4 years (2021 to 2025), Imax's R&D has grown at a -4.3% compound annual growth rate (CAGR), from $6.94M to $5.82M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Imax's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude